Navigation Links
ADVENTRX Announces Completion of Patient Enrollment in Phase 2 Clinical Trial of CoFactor(R) for the Treatment of Advanced Breast Cancer
Date:12/5/2007

d development company focused on commercializing proprietary product candidates for the treatment of cancer and infectious diseases. The Company seeks to improve the performance and safety of existing treatments by addressing significant problems, such as drug metabolism and bioavailability, excessive toxicity and treatment resistance. More information can be found on ADVENTRX's web site at http://www.adventrx.com.

Forward Looking Statements

ADVENTRX cautions you that statements included in this press release that are not a description of historical facts are forward-looking statements that involve risks and assumptions that, if they materialize or do not prove to be accurate, could cause ADVENTRX's results to differ materially from historical results or those expressed or implied by such forward-looking statements. These risks and uncertainties include, but are not limited to: the risk that ADVENTRX will be unable to partner its product candidates and the terms of any related transaction; the results of pending clinical trials; the potential for ADVENTRX's product candidates to receive regulatory approval for one or more indications on a timely basis or at all, and the uncertain process of seeking regulatory approval; difficulties or delays in developing, testing, manufacturing and marketing of and obtaining regulatory approval for ADVENTRX's product candidates; the market potential for ADVENTRX's product candidates and ADVENTRX's and any future partners' ability to compete in those markets; unexpected adverse side effects or inadequate therapeutic efficacy of ADVENTRX's product candidates that could delay or prevent regulatory approval or commercialization, or that could result in recalls or product liability claims; the risk that preclinical and clinical results are not indicative of the success of subsequent clinical trials and that products will not perform as preclinical and clinical data sugges
'/>"/>

SOURCE ADVENTRX Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
2. ADVENTRX Announces Completion of Patient Enrollment in ANX-530 Marketing-Enabling Clinical Study
3. ADVENTRX Meets Primary Endpoint in ANX-530 Marketing-Enabling Clinical Study
4. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
5. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
6. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
7. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
8. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
9. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
10. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
11. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... SEATTLE , BERKELEY, Kalifornien, und KOPENHAGEN, ... CMC Biologics, Inc. , ein Weltmarktführer der ... und anderen therapeutischen Proteinen, gab heute bekannt, ... Expansionsstrategie der Produktionskapazität den Ausbau der nordamerikanischen ... , mit der Ergänzung  einer Einweg-Anlage Bioreactor ...
(Date:6/30/2015)... June 30, 2015  EnteroMedics Inc. (NASDAQ: ETRM ... neuroblocking technology to treat obesity, metabolic diseases, and other ... public offering  of 40,229,886 units. Each unit consists of ... A warrant to purchase one share of common stock, ... one share of common stock, at a purchase price ...
(Date:6/30/2015)... 2015  Egalet Corporation (Nasdaq: EGLT ... company focused on developing, manufacturing and marketing ... from a Category 3 human abuse liability ... oral oxycodone product candidate in late-stage clinical ... enough to require daily, around-the-clock opioid treatment ...
Breaking Medicine Technology:CMC Biologics baut GMP-Produktionskapazität in den USA aus 2CMC Biologics baut GMP-Produktionskapazität in den USA aus 3EnteroMedics Inc. Announces Pricing of $35.0 Million Public Offering of Common Stock and Warrants 2EnteroMedics Inc. Announces Pricing of $35.0 Million Public Offering of Common Stock and Warrants 3Egalet Announces Top-Line Results from Oral Human Abuse Liability Study of Egalet-002 2Egalet Announces Top-Line Results from Oral Human Abuse Liability Study of Egalet-002 3Egalet Announces Top-Line Results from Oral Human Abuse Liability Study of Egalet-002 4Egalet Announces Top-Line Results from Oral Human Abuse Liability Study of Egalet-002 5
... YONKERS, N.Y., Sept. 27, 2011 As a result ... that could be dangerous to their health, according to ... Americans who currently take a prescription medicine told pollsters ... a doctor,s visit or medical procedure, declining tests, or ...
... Pa., Sept. 27, 2011 Inovio Pharmaceuticals, Inc. (NYSE ... development of synthetic immunogens against cancers and infectious diseases, ... Research and Development Agreement (CRADA) with the United States ... Plum Island Animal Disease Center. This collaboration will evaluate ...
Cached Medicine Technology:Consumer Reports Poll: 48 Percent of Americans on Meds Making Risky Health Care Tradeoffs 2Consumer Reports Poll: 48 Percent of Americans on Meds Making Risky Health Care Tradeoffs 3Consumer Reports Poll: 48 Percent of Americans on Meds Making Risky Health Care Tradeoffs 4Consumer Reports Poll: 48 Percent of Americans on Meds Making Risky Health Care Tradeoffs 5Inovio Pharmaceuticals Enters Collaboration With U.S. Dept. of Homeland Security to Assess Foot & Mouth Disease Synthetic Vaccines' Potential to Help Ensure Nation's Food Supply Safety 2Inovio Pharmaceuticals Enters Collaboration With U.S. Dept. of Homeland Security to Assess Foot & Mouth Disease Synthetic Vaccines' Potential to Help Ensure Nation's Food Supply Safety 3Inovio Pharmaceuticals Enters Collaboration With U.S. Dept. of Homeland Security to Assess Foot & Mouth Disease Synthetic Vaccines' Potential to Help Ensure Nation's Food Supply Safety 4
(Date:6/30/2015)... ... June 30, 2015 , ... ... to announce it’s own Debby Mann, CPC, RCC, ROCC, Coding Documentation and Education ... with the Special Recognition Award for her contribution to the RBMA Coding Subcommittee. ...
(Date:6/30/2015)... ... 2015 , ... Trenton Health Team has been certified by the New Jersey ... in the State, serving the greater Trenton community. The ACO pilot is for ... on the collaborative structure of THT, bringing together the vast majority of Trenton’s primary ...
(Date:6/30/2015)... (PRWEB) , ... June 30, 2015 , ... ... Good Neighbor Pharmacy’s premier event and tradeshow, taking place July 29 to August ... purchasing decision makers. , ThoughtSpot is a four-day event for independent ...
(Date:6/30/2015)... ... June 30, 2015 , ... The American Lung Association ... a media event in San Diego. Speakers and clean air advocates included San Diego ... Natalie Germuska of Kindred Hospital, and Daniel Sullivan, founder and president of Sullivan Solar ...
(Date:6/30/2015)... ... June 30, 2015 , ... University Post-Acute Rehab ... focuses on the rehab center’s patients and their experiences at the facility. Medicare ... of services available. Each patient attests to the high rating, which is predominantly ...
Breaking Medicine News(10 mins):Health News:ADVOCATE’s Debby Mann Honored With Special Recognition Award 2Health News:Trenton Health Team Certified as Medicaid Accountable Care Organization 2Health News:Trenton Health Team Certified as Medicaid Accountable Care Organization 3Health News:Retail Management Solutions to Attend Amerisource's ThoughtSpot 2015 Conference and Trade Show 2Health News:Retail Management Solutions to Attend Amerisource's ThoughtSpot 2015 Conference and Trade Show 3Health News:Local Dignitaries Gather to Announce San Diego’s Clean Air Challenge 2Health News:Local Dignitaries Gather to Announce San Diego’s Clean Air Challenge 3Health News:Patients of University Post-Acute Rehab Support Five-Star Rating in New Video 2
... produced audio or video for a internet directory or their ... Jeff Fisher, the developer of CounsellingBC.com ... word can provide when selecting a therapist from one of ... It,s a new phenomenon that is bound to gain ...
... The Minnesota Chiropractic Association (MCA) recently honored twelve (12) doctors for ... Madden,s in Brainerd, recognized those among them who have consistently supported ... health. Those honored were:, , ... Dr. Douglas Edwards, Albert Lea, MN ...
... and Honorary Chair Kristin Davis of acclaimed show Sex ... Hospital on Thursday, May 28th 2009, 8:00pm at Capitale to ... au Vin Affair, . It,s a first for New York ... with a musical performance by the legendary Tony Bennett, gourmet ...
... Weigh in on Kidz-Med ThermofocusWESTON, Fla., May 22 ... (Pink Sheets: ASFX) is excited to see that awareness ... is increasing surrounding taking a child,s temperature with the ... daytime talk show The Doctors , renowned pediatrician ...
... (Nasdaq: CRDC ) today announced that, on ... Listing Qualifications Department of The NASDAQ Global Market (NASDAQ) ... $10 million stockholders, equity requirement for continued listing on ... Rule 5450(b)(1)(A) (the "Minimum Equity Requirement"). As provided by ...
... goals is what leads to well-being , , FRIDAY, May 22 ... fame may sound like a sure ticket to happiness, but ... of Rochester in New York tracked 147 college graduates, evaluating ... -- one year after graduation, and then 12 months later. ...
Cached Medicine News:Health News:What's in a Video or a Sound Bite When You're Looking for a Therapist? 2Health News:What's in a Video or a Sound Bite When You're Looking for a Therapist? 3Health News:Celebrities to Highlight at St. Jude's Inaugural Wine and Chocolate Gala 2Health News:Awareness Increases on New Health and Safety Technology for Kids 2Health News:Awareness Increases on New Health and Safety Technology for Kids 3Health News:Cardica Receives NASDAQ Notification 2Health News:Looks, Money, Fame Don't Bring Happiness 2
... Integra II SP MRI-Compatible Anesthesia System is perfect ... more than one type of anesthetic agent. ... and due to its wider stance, has a ... ventilator bellows assembly is utilized in both the ...
... Market leader in soft tissue repair in ... has developed the latest evolution in orthopedic ... ORTHOCORD Suture is as strong as any ... importantly, ORTHOCORD Suture handles like ETHIBOND®., ,ORTHOCORD ...
... PURPLE NITRILE* product family offers a comprehensive ... gloves were designed as an alternative for ... hypersensitivity to natural rubber latex proteins. The ... from latex and other synthetic gloves. Custom ...
... and the distinctive COLOR PURPLE* distinguish ... them for sterile clinical procedures when ... required. Theyre designed as an alternative ... Type 1 hypersensitivity to natural rubber ...
Medicine Products: